Company Description
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States.
Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment.
In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services.
The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
| Country | United States |
| IPO Date | Oct 25, 2019 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 566 |
| CEO | Peter Anevski |
Contact Details
Address: 1359 Broadway, 2nd Floor New York, New York 10018 United States | |
| Phone | 212-888-3124 |
| Website | progyny.com |
Stock Details
| Ticker Symbol | PGNY |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $13.00 |
| CIK Code | 0001551306 |
| CUSIP Number | 74340E103 |
| ISIN Number | US74340E1038 |
| Employer ID | 27-2220139 |
| SIC Code | 8090 |
Key Executives
| Name | Position |
|---|---|
| David J. Schlanger | Executive Chairman |
| Peter Anevski | Chief Executive Officer and Director |
| Michael Sturmer | President |
| Mark S. Livingston | Chief Financial Officer |
| Allison Swartz | General Counsel and Secretary |
| Steven Leist | Chief Technology Officer |
| James Hart | Vice President of Investor Relations |
| Risa Fisher | Chief Marketing Officer |
| Cassandra Pratt | Chief Human Resources Officer |
| Julie Stadlbauer | Chief Business Development Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 12, 2024 | ARS | Filing |
| Apr 12, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 12, 2024 | DEF 14A | Other definitive proxy statements |
| Apr 1, 2024 | 144 | Filing |
| Apr 1, 2024 | 144 | Filing |
| Mar 1, 2024 | 144 | Filing |
| Mar 1, 2024 | 144 | Filing |
| Feb 29, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 29, 2024 | 10-K | Annual Report |
| Feb 27, 2024 | 8-K | Current Report |